Therapeutic potential of microbes and microbial products in the management of human allergic asthma

Bibliography

• LAZAAR AL, PANETTIERI RA: Pathogenesis and treatment of asthma: recent advances. Drug Discov. Today Dis. Mech. (2004) 1(1):111–116.
   Google Scholar
• LUKACS NW: Role of chemokines in the pathogenesis of asthma. Nat. Rev. Immunol (2001) 1(2):108–116.
   Google Scholar
• HEATON T, ROWE J, TURNER S et al: An immunoepidemiological approach to asthma: identification of in vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet (2005) 365(9454):142–149.
   PubMedGoogle Scholar
• •This paper highlights the heterogeneity of immune response patterns in asthmatic children, even those with seemingly homogeneous TH2-driven atopic asthma.
   Google Scholar
• KAPLAN AP: A new mechanism for immunologic initiation of asthma. Proc. Nail. Acad. Sci. USA (2005) 102(5):1267–1268.
   Google Scholar
• THE INT. STUDY OF ASTHMA AND ALLERGIES IN CHILDHOOD (ISAAC) STEERING COMMITTEE: Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet (1998) 351(9110:1225–1232.
   Google Scholar
• ELIAS JA, LEE CG, ZHENG T, MA B, HOMER RJ, ZHU Z: New insights into the pathogenesis of asthma. J. Clin. Invest. (2003) 111(3):291–297.
   Google Scholar
• WEINBERGER M: Respiratory infections and asthma: current treatment strategies. Drug Discov. Today (2004) 9(19):831–837.
   Google Scholar
• •A comprehensive review on the potential contribution of lower respiratory illness, their treatment to the initiation of asthma and major factors in recurring acute exacerbations of the condition.
   Google Scholar
• DOUWES J, LE GROS G, GIBSON P, PEARCE N: Can bacterial endotoxin exposure reverse atopy and atopic disease? J. Allergy Clin. Immunol (2004) 114(5):1051–1054.
   Google Scholar
• ••A critical analysis of the epidemiological and experimental data on the potential effect of endotoxin exposure on the reversion of established allergic airway inflammation and atopic diseases, an extension of 'hygiene hypothesis.
   Google Scholar
• SINGH J, SCHWARTZ DA: Endotoxin and the lung: Insight into the host-environment interaction. J. Allergy Clin. Immunol (2005) 115(2):330–333.
   Google Scholar
• ••A brief overview on the recent majordiscoveries and future research directions of the role of endotoxin in the development of asthma and COPD.
   Google Scholar
• HORNER AA, RAZE: Do microbes influence the pathogenesis of allergic diseases? Building the case for Toll-like receptor ligands. Curr. Opin. Immunol (2003) 15(6):614–619.
   Google Scholar
• ••An in-depth review of the role of microbesin the development of asthma and the potential molecular interactions between immunocytes and microbes.
   Google Scholar
• UMETSU DT: Revising the immunological theories of asthma and allergy. Lancet (2005) 365045098–100.
   Google Scholar
• AKBARI 0, STOCK P, DEKRUYFF RH, UMETSU DT: Role of regulatory T cells in allergy and asthma. Curr. Opin. Immunol (2003) 15(6):627–633.
   Google Scholar
• ••An in-depth review on the critical role ofregulatory T cells (TH3 cells, TR cells, CD4*CD25* cells and NKT cells) in the immunopathogenesis of allergy and asthma.
   Google Scholar
• STRACHAN DP: Hay fever, hygiene, andhousehold size. Br. Med. J. (1989) 299(6710):1259–1260.
   PubMed Web of Science ®Google Scholar
• ERB KJ, HOLLOWAY JW, SOBECK A, MOLL H, LE GROS G: Infection of mice with Mycobacterium bovis-Bacillus Calmette-Guerin (BCG) suppresses allergen-induced airway eosinophilia. J. Exp. Med. (1998) 187(4):561–569.
   PubMed Web of Science ®Google Scholar
• NAHORI MA, LAGRANDERIE M, LEFORT J et al.: Effects of Mycobacterium bovis BCG on the development of allergic inflammation and bronchial hyperresponsiveness in hyper-IgE BP2 mice vaccinated as newborns. Vaccine (2001) 19(11-12):1484–1495.
   PubMedGoogle Scholar
• TUKENMEZ F, BAHCECILER NN, BARLAN IB, BASARAN MM: Effect of pre-immunization by killed Mycobacterium bovis and vaccae on immunoglobulin E response in ovalbumin-sensitized newborn mice. Pediam. Allergy Immunol. (1999) 10(2):107–111.
   PubMed Web of Science ®Google Scholar
• NOVERR MC, HUFFNAGLE GB: Does the microbiota regulate immune responses outside the gut? Trends Microbiol (2004) 12(12):562–568.
   PubMed Web of Science ®Google Scholar
• •A comprehensive review of the evidence that perturbations in the gastrointestinal microflora by antibiotics and diet in 'westernised' countries are strongly associated with allergies and asthma.
   Google Scholar
• SHIRAKAWA T, ENOMOTO T, SHIMAZU S, HOPKIN JM: The inverse association between tuberculin responses and atopic disorder. Science (1997) 275(5296):77–79.
   Google Scholar
• MCINTIRE JJ, UMETSU SE, MACAUBAS C et al.: Immunology: hepatitis A virus link to atopic disease. Nature (2003) 425(6958):576.
   PubMedGoogle Scholar
• HANSEN G, YEUNG VP, BERRY G, UMETSU DT, DEKRUYFF RH: Vaccination with heat-killed Listeria as adjuvant reverses established allergen-induced airway hyperreactivity and inflammation: role of CD8* T cells and IL-18.J. Immunol (2000) 164(0:223–230.
   Google Scholar
• ZUANY-AMORIM C, MANLIUS C, TRIFILIEFF A et al.: Long-term protective and antigen-specific effect of heat-killed Mycobacterium vaccae in a murine model of allergic pulmonary inflammation. Immunol (2002) 169(3):1492–1499.
   Google Scholar
• ZUANY-AMORIM C, SAWICKA E, MANLIUS C et al.: Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. (2002) 8(0:625–629.
   Google Scholar
• MAJOR T: WOHLLEBEN G, REIBETANZ B, ERB KJ: Application of heat killed Mycobacterium bovis-BCG into the lung inhibits the development of allergen-induced TH2 responses. Vaccine (2002) 20(11-12):1532–1540.
   Google Scholar
• SMIT JJ, VAN LOVEREN H, HOEKSTRA MO, VAN DER KANT PA, FOLKERTS G, NIJKAMP FP: Therapeutic treatment with heat-killed Mycobacterium vaccae (SRL172) in a mild and severe mouse model for allergic asthma. Eur. J. PharmacoL (2003) 470(3):193–199.
   Google Scholar
• HERZ U, GERHOLD K, GRUBER C et al.: BCG infection suppresses allergic sensitization and development of increased airway reactivity in an animal model. J. Allergy Clin. ImmunoL (1998) 102(5):867–874.
   PubMed Web of Science ®Google Scholar
• HYLKEMA MN, TIMENS W, LUINGE M, VAN DER WN, HOEKSTRA MO: The effect of Bacillus Calmette-Guerin immunization depends on the genetic predisposition to T2-type responsiveness. Am. J. Respir. Cell Mot Biol. (2002) 27(2):244–249.
   Google Scholar
• SAYERS I, SEVERN W, SCANGA CB, HUDSON J, LE GROS G, HARPER JL: Suppression of allergic airway disease using mycobacterial lipoglycans. J. Allergy Clin. ImmunoL (2004) 114(2):302–309.
   Google Scholar
• ••This research paper identifies themycobacterial cell wall lipoglycans lipoarabinomannan and phosphatidylinositol mannan as components of mycobacteria responsible for the protective effects observed in allergic disease.
   Google Scholar
• ENNIS DP, CASSIDY JP, MAHON BP: Prior Bordetella pertussis infection modulates allergen priming and the severity of airway pathology in a murine model of allergic asthma. Clin. Exp. Allergy (2004) 34(9):1488–1497.
   Google Scholar
• KIM YS, KWON KS, KIM DK, CHOI IW, LEE HK: Inhibition of murine allergic airway disease by Bordetella pertussis. Immunology (2004) 112(4):624–630.
   Google Scholar
• ENNIS DP, CASSIDY JP, MAHON BP: Whole-cell pertussis vaccine protects against Bordetella pertussis exacerbation of allergic asthma. ImmunoL Lett. (2005) 97(1):91–100.
   Google Scholar
• YEUNG VP, GIENI RS, UMETSU DT, DEKRUYFF RH: Heat-killed Listeria monocytogenes as an adjuvant converts established murine TH2-dominated immune responses into TH1-dominated responses. J. ImmunoL (1998) 161(8):4146–4152.
   Google Scholar
• BILENKI L, WANG S, FAN Y, YANG J, HAN X, YANG X: Chlamydia trachomatis infection inhibits airway eosinophilic inflammation induced by ragweed. Clin. Immunol. (2002) 102(1):28–36.
   Google Scholar
• HAN X, FAN Y, WANG S et al.: Dendritic cells from Chlamydia-infected mice show altered Toll-like receptor expression and play a crucial role in inhibition of allergic responses to ovalbumin. Eur. j ImmunoL (2004) 34(4):981–989.
   Google Scholar
• BRAUN-FAHRLANDER C: Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: evaluating developments since April 2002. Curr. Opin. Allergy Clin. ImmunoL (2003) 3(5):325–329.
   PubMedGoogle Scholar
• EISENBARTH SC, PIGGOTT DA, HULEATT JW, VISINTIN I, HERRICK CA, BOTTOMLY K: Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell Type 2 responses to inhaled antigen. J. Exp. Med. (2002) 196(12):1645–1651.
   PubMed Web of Science ®Google Scholar
• ••An excellent research paper shows that thelevel of LPS exposure determines the type of inflammatory response generated, therefore, providing a potential mechanistic explanation of epidemiological data on endotoxin exposure and asthma prevalence.
   Google Scholar
• RODRIGUEZ D, KELLER AC, FAQUIM-MAURO EL et al.: Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. ImmunoL (2003) 171(2):1001–1008.
   Google Scholar
• HORNER AA, TAKABAYSAHI K, ZUBELDIA JM, RAZ E: Immunostimulatory DNA-based therapeutics for experimental and clinical allergy. Allergy (2002) 57\(Supp1.72)24–29.
   Google Scholar
• HORNER AA, TAKABAYASHI K, BECK Let al.: Optimized conjugation ratios lead to allergen immunostimulatory oligodeoxynucleotide conjugates with retained immunogenicity and minimal anaphylactogenicity. J. Allergy Clin. ImmunoL (2002) 110(3):413–420.
   Google Scholar
• JAIN VV, BUSINGA TR, KITAGAKI K, GEORGE CL, O'SHAUGHNESSY PT, KLINE JN: Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am. J. PhysioL Lung Cell MoL PhysioL (2003) 285(5):L1137–L1146.
   Google Scholar
• •This paper demonstrates the potential of mucosal administration of CpG DNA (oligonucleotides) for prophylactic and therapeutic treatment of experimental allergic asthma.
   Google Scholar
• KLINE JN, KITAGAKI K, BUSINGA TR., JAIN VV: Treatment of established asthma in a murine model using CpG oligodeoxynucleotides. Am. J. PhysioL Lung CelL MoL PhysioL (2002) 283(1):L170–L179.
   Google Scholar
• KLINE JN, WALDSCHMIDT TJ, BUSINGA TR et al.: Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J. ImmunoL (1998) 160(61:2555–2559.
   Google Scholar
• ILLI S, VON MUTIUS E, LAU S et al.: Early childhood infectious diseases and the development of asthma up to school age: a birth cohort study. Br. Med. J. (2001) 322(7283):390–395.
   PubMed Web of Science ®Google Scholar
• MARSLAND BJ, HARRIS NL, CAMBERIS M, KOPF M, HOOK SM, LE GROS G: Bystander suppression of allergic airway inflammation by lung resident memory CD8* T cells. Proc. Nail. Acad. Sci. USA (2004) 101(16):6116–6121.
   Google Scholar
• WOHLLEBEN G, MULLER J, TATSCH U et al.: Influenza A virus infection inhibits the efficient recruitment of TH2 cells into the airways and the development of airway eosinophilia. ImmunoL (2003) 170(9):4601–4611.
   Google Scholar
• ••This research paper demonstrates that,depending on the temporal relationship with the allergen exposure, flu virus infections can induce, exacerbate and suppress features of asthmatic disease in mice.
   Google Scholar
• DAHL ME, DABBAGH K, LIGGITT D, KIM S, LEWIS DB: Viral-induced T helper Type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat. ImmunoL (2004) 5(3):337–343.
   Google Scholar
• MARSLAND BJ, KOPF M, LE GROS G: Viral infection and allergy. Nat. ImmunoL (2004) 5(9):865–866.
   Google Scholar
• ARAUJO MI, HOPPE B, MEDEIROS M JR et al.: Impaired T helper 2 response to aeroallergen in helminth-infected patients with asthma. J. Infect. Dis. (2004) 190(141797–1803.
   Google Scholar
• VARGAS MH, BERNAL-ALCANTARA DA, VACA MA, FRANCO-MARINA F, LASCURAIN R: Effect of BCG vaccination in asthmatic schoolchildren. Pediatr. Allergy ImmunoL (2004) 15(5):415–420.
   Google Scholar
• PULENDRAN B, KUMAR P, CUTLER CW, MOHAIVIADZADEH M, VAN DYKE T, BANCHEREAU J: Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immund. (2001) 167(9):5067–5076.
   PubMed Web of Science ®Google Scholar
• TAKEDA K, KAISHO T, AKIRA S: Toll-like receptors. Ann. Rev. Immund. (2003) 21:335–376.
   PubMed Web of Science ®Google Scholar
• O'NEILL LA: After the toll rush. Science (2004) 303(5663):1481–1482.
   Google Scholar
• KAISHO T, AKIRA S: Pleiotropic function of Toll-like receptors. Microbes Infect. (2004) 6(15):1388–1394.
   Web of Science ®Google Scholar